Northwestern Mutual Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.13M | Sell |
11,532
-1,505
| -12% | -$670K | ﹤0.01% | 675 |
|
|
2025
Q1 | $6.32M | Buy |
13,037
+490
| +4% | +$238K | 0.01% | 592 |
|
|
2024
Q4 | $5.05M | Buy |
12,547
+150
| +1% | +$60.4K | ﹤0.01% | 620 |
|
|
2024
Q3 | $5.77M | Sell |
12,397
-3,545
| -22% | -$1.65M | 0.01% | 582 |
|
|
2024
Q2 | $7.47M | Buy |
15,942
+7,647
| +92% | +$3.58M | 0.01% | 490 |
|
|
2024
Q1 | $3.47M | Sell |
8,295
-322
| -4% | -$135K | ﹤0.01% | 650 |
|
|
2023
Q4 | $3.51M | Buy |
8,617
+510
| +6% | +$207K | ﹤0.01% | 623 |
|
|
2023
Q3 | $2.82M | Sell |
8,107
-781
| -9% | -$272K | ﹤0.01% | 636 |
|
|
2023
Q2 | $3.13M | Sell |
8,888
-774
| -8% | -$272K | ﹤0.01% | 601 |
|
|
2023
Q1 | $3.04M | Buy |
9,662
+122
| +1% | +$38.4K | ﹤0.01% | 586 |
|
|
2022
Q4 | $2.75M | Buy |
9,540
+416
| +5% | +$120K | ﹤0.01% | 592 |
|
|
2022
Q3 | $2.64M | Sell |
9,124
-23
| -0.3% | -$6.66K | ﹤0.01% | 547 |
|
|
2022
Q2 | $2.58M | Sell |
9,147
-433
| -5% | -$122K | ﹤0.01% | 563 |
|
|
2022
Q1 | $2.5M | Buy |
9,580
+2,024
| +27% | +$528K | ﹤0.01% | 588 |
|
|
2021
Q4 | $1.66M | Buy |
7,556
+1,995
| +36% | +$438K | ﹤0.01% | 660 |
|
|
2021
Q3 | $1.01M | Sell |
5,561
-662
| -11% | -$120K | ﹤0.01% | 767 |
|
|
2021
Q2 | $1.26M | Sell |
6,223
-4,001
| -39% | -$807K | ﹤0.01% | 690 |
|
|
2021
Q1 | $2.2M | Sell |
10,224
-3,385
| -25% | -$727K | ﹤0.01% | 493 |
|
|
2020
Q4 | $3.22M | Buy |
13,609
+2,444
| +22% | +$578K | 0.01% | 390 |
|
|
2020
Q3 | $3.04M | Buy |
11,165
+8,223
| +280% | +$2.24M | 0.01% | 362 |
|
|
2020
Q2 | $855K | Buy |
2,942
+773
| +36% | +$225K | ﹤0.01% | 572 |
|
|
2020
Q1 | $516K | Buy |
2,169
+268
| +14% | +$63.8K | ﹤0.01% | 634 |
|
|
2019
Q4 | $416K | Sell |
1,901
-328
| -15% | -$71.8K | ﹤0.01% | 728 |
|
|
2019
Q3 | $378K | Sell |
2,229
-55
| -2% | -$9.33K | ﹤0.01% | 702 |
|
|
2019
Q2 | $419K | Buy |
2,284
+122
| +6% | +$22.4K | ﹤0.01% | 681 |
|
|
2019
Q1 | $398K | Buy |
2,162
+281
| +15% | +$51.7K | ﹤0.01% | 678 |
|
|
2018
Q4 | $312K | Sell |
1,881
-60
| -3% | -$9.95K | ﹤0.01% | 680 |
|
|
2018
Q3 | $374K | Buy |
1,941
+125
| +7% | +$24.1K | ﹤0.01% | 633 |
|
|
2018
Q2 | $309K | Buy |
1,816
+338
| +23% | +$57.5K | ﹤0.01% | 654 |
|
|
2018
Q1 | $241K | Buy |
1,478
+410
| +38% | +$66.9K | ﹤0.01% | 694 |
|
|
2017
Q4 | $160K | Buy |
1,068
+49
| +5% | +$7.34K | ﹤0.01% | 789 |
|
|
2017
Q3 | $155K | Buy |
1,019
+31
| +3% | +$4.72K | ﹤0.01% | 764 |
|
|
2017
Q2 | $127K | Buy |
988
+132
| +15% | +$17K | ﹤0.01% | 811 |
|
|
2017
Q1 | $93K | Sell |
856
-547
| -39% | -$59.4K | ﹤0.01% | 848 |
|
|
2016
Q4 | $103K | Buy |
+1,403
| New | +$103K | ﹤0.01% | 817 |
|
|
2016
Q3 | – | Sell |
-1,351
| Closed | -$116K | – | 1497 |
|
|
2016
Q2 | $116K | Sell |
1,351
-166
| -11% | -$14.3K | ﹤0.01% | 686 |
|
|
2016
Q1 | $120K | Buy |
1,517
+357
| +31% | +$28.2K | ﹤0.01% | 657 |
|
|
2015
Q4 | $146K | Buy |
1,160
+906
| +357% | +$114K | ﹤0.01% | 567 |
|
|
2015
Q3 | $26K | Sell |
254
-48
| -16% | -$4.91K | ﹤0.01% | 854 |
|
|
2015
Q2 | $37K | Buy |
302
+53
| +21% | +$6.49K | ﹤0.01% | 737 |
|
|
2015
Q1 | $29K | Buy |
249
+34
| +16% | +$3.96K | ﹤0.01% | 780 |
|
|
2014
Q4 | $26K | Buy |
215
+15
| +8% | +$1.81K | ﹤0.01% | 820 |
|
|
2014
Q3 | $22K | Hold |
200
| – | – | ﹤0.01% | 805 |
|
|
2014
Q2 | $19K | Buy |
200
+36
| +22% | +$3.42K | ﹤0.01% | 780 |
|
|
2014
Q1 | $12K | Sell |
164
-471
| -74% | -$34.5K | ﹤0.01% | 845 |
|
|
2013
Q4 | $47K | Buy |
635
+587
| +1,223% | +$43.4K | ﹤0.01% | 615 |
|
|
2013
Q3 | $4K | Buy |
+48
| New | +$4K | ﹤0.01% | 1061 |
|